M. Varela

发表

Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402).

E. Espinosa, M. Redrado, D. Rodríguez-Abreu, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.